Cargando…

M191. EFFECT OF BREXPIPRAZOLE ON ENGAGEMENT IN PATIENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF THREE STUDIES

BACKGROUND: In schizophrenia, a patient’s quality of life and level of psychosocial functioning is dependent on two key domains: the severity of their psychotic symptoms, and the side effects of antipsychotic medication. In addition, people with schizophrenia experience motivation deficits, thus pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ismail, Zahinoor, Pedersen, Anne M, Thase, Michael E, Rasmussen Meehan, Stine, Weiss, Catherine, Groes Larsen, Klaus, Chen, Dalei, Nylander, Anna-Greta, Baker, Ross A, McIntyre, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session II
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234454/ http://dx.doi.org/10.1093/schbul/sbaa030.503

Ejemplares similares

Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews
por: Weiss, Catherine, et al.
Publicado: (2021)

Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies
por: Meade, Nicole, et al.
Publicado: (2020)

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
por: Thase, Michael E, et al.
Publicado: (2018)

Effects of Brexpiprazole Across Symptom Domains in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies
por: Marder, Stephen R, et al.
Publicado: (2021)

Patient-reported outcome measures for life engagement in mental health: a systematic review
por: McIntyre, Roger S., et al.
Publicado: (2022)

Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial
por: Lee, Daniel, et al.
Publicado: (2023)

Adjunctive Brexpiprazole and Functioning in Major Depressive Disorder: A Pooled Analysis of Six Randomized Studies Using the Sheehan Disability Scale
por: Hobart, Mary, et al.
Publicado: (2018)

M104. THE USE OF SHORT MESSAGE SERVICE AS A MEANS OF CLINICAL ENGAGEMENT IN EARLY PSYCHOSIS
por: D’Arcey, Jessica, et al.
Publicado: (2020)

Life Engagement Improvement Following Initiation of Brexpiprazole Treatment in Patients with MDD: A Naturalistic, Retrospective Real-World Study
por: Wee, Soon Nan, et al.
Publicado: (2023)

M235. BUILDING A GROUNDED THEORY OF ENGAGEMENT IN MINDFULNESS BASED GROUP THERAPY FOR DISTRESSING VOICES
Publicado: (2020)

O7.5. LONG-TERM SAFETY AND TOLERABILITY OF BREXPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA
por: Hakala, Mika, et al.
Publicado: (2018)

Efficacy of Brexpiprazole as Adjunctive Treatment in Major Depressive Disorder With Irritability: Post Hoc Analysis of 2 Pivotal Clinical Studies
por: Fava, Maurizio, et al.
Publicado: (2017)

PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies
por: Eriksson, Hans, et al.
Publicado: (2016)

M248. VOICE PATTERNS IN SCHIZOPHRENIA: A CROSS-LINGUISTIC REPLICATION OF PREVIOUS META-ANALYTIC FINDINGS
por: Parola, Alberto, et al.
Publicado: (2020)

M162. FRONTO-STRIATAL-THALAMIC CIRCUITRY ABNORMALITIES IN WHITE MATTER TRACTS IN INDIVIDUALS WITH 22Q11.2 DELETION SYNDROME
por: Heller, Carina, et al.
Publicado: (2020)

M71. THE INFLUENCE OF METACOGNITIVE CAPACITIES ON SPECIFIC NEGATIVE SYMPTOMS: A SYSTEMATIC REVIEW AND INDIVIDUAL PARTICIPANT META-ANALYSIS OF INTERVIEW-BASED DATA
por: McGuire, Nicola, et al.
Publicado: (2020)

T191. FRONTO-CORTICAL ROLES OF NIGELLA SATIVA IN SOCIALLY ISOLATED MICE
por: Folarin, Royhaan, et al.
Publicado: (2020)

S191. A SCOPING REVIEW AND PHENOMENOLOGICAL EVALUATION OF METACOGNITIVE TRAINING FOR SCHIZOPHRENIA
por: Brar, Pavan, et al.
Publicado: (2020)

Effect of Brexpiprazole on Prolactin and Sexual Functioning: An Analysis of Short- and Long-Term Study Data in Major Depressive Disorder
por: Clayton, Anita H., et al.
Publicado: (2020)

M67. UNDERSTANDING SOCIAL COGNITION IN SCHIZOPHRENIA THROUGH THE LENS OF SCHIZOTYPY
por: Lee, Sara-Ann, et al.
Publicado: (2020)

M38. PATIENT-PERSPECTIVE: NEED FOR CARE AFTER A FIRST PSYCHOSIS
por: Heijden-Hobus, Inge, et al.
Publicado: (2020)

M73. DRIVING ABILITIES IN PATIENTS WITH SCHIZOPHRENIA
por: Pardeller, Silvia, et al.
Publicado: (2020)

M31. THE ASSOCIATION BETWEEN BULLYING VICTIMIZATION AND PSYCHOSIS AND THE MEDIATING ROLE OF PEER AND FAMILY SOCIAL SUPPORT
por: Shannon, Ciaran, et al.
Publicado: (2020)

M246. DIGITAL SELF-MONITORING AND EMBODIMENT IN FIRST EPISODE PSYCHOSIS: ETHICAL CONSIDERATIONS
por: Berkhout, Susan, et al.
Publicado: (2020)

M49. BEHAVIOURAL SOCIAL COGNITION IN SCHIZOPHRENIA SPECTRUM DISORDERS IN COMPARISON TO AUTISM SPECTRUM DISORDER: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Oliver, Lindsay, et al.
Publicado: (2020)

M1. INVESTIGATING THE RELATIONSHIP BETWEEN CHILDHOOD TRAUMA AND PSYCHIATRIC DISEASE USING MACHINE LEARNING TECHNIQUES
por: Haidl, Theresa, et al.
Publicado: (2020)

M12. INCREASED SAFETY BEHAVIOR IN SUBJECTS WITH CHILDHOOD TRAUMA AND DELUSIONS
por: Conring, Frauke, et al.
Publicado: (2020)

M46. THE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH SCHIZOPHRENIA
por: Jang, Seung-Ho, et al.
Publicado: (2020)

M18. REDUCED CORTICAL CEREBRAL BLOOD FLOW IN FIRST EPISODE PSYCHOSIS PATIENTS
por: Selvaggi, Pierluigi, et al.
Publicado: (2020)

M82. GROWING BURDEN OF DISEASE: THE PREVALENCE OF CHRONIC HEALTH CONDITIONS AFTER A FIRST EPISODE OF PSYCHOSIS
por: Rodrigues, Myanca, et al.
Publicado: (2020)

M226. ECOLOGICAL MOMENTARY ASSESSMENT OF REAL-WORLD FUNCTIONING IN SCHIZOPHRENIA: MODERATING EFFECTS OF COGNITIVE AND FUNCTIONAL ABILITY STATUS
por: Mahmood, Zanjbeel, et al.
Publicado: (2020)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

M24. NETWORK STRUCTURE OF PSYCHOPATHOLOGY SYMPTOMS IN A COMMUNITY SAMPLE OF YOUTH
por: Wang, Emily, et al.
Publicado: (2020)

M30. THE ASSOCIATION OF PEER-REPORTED BULLYING AND SOCIAL NETWORK CHARACTERISTICS WITH PSYCHOTIC EXPERIENCES IN CHILDHOOD
por: Steenkamp, Lisa, et al.
Publicado: (2020)

M9. RATS REARED IN SOCIAL ISOLATION INDUCES EPIGENETIC MODIFICATIONS IN THE NMDA RECEPTOR SUBUNITS
por: Loureiro, Camila, et al.
Publicado: (2020)

M231. INTERNALIZED STIGMA AS A PREDICTOR OF EMPLOYMENT STATUS IN PATIENTS WITH SCHIZOPHRENIA
por: Yi Sum, Min, et al.
Publicado: (2020)

M240. THE RELATIONSHIP OF TREATMENT DELAY WITH PERSONALITY TRAIT AND FAMILY COHESION IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDER
por: Jo, Anna, et al.
Publicado: (2020)

M237. EMOTIONAL INTELLIGENCE AND QUALITY OF LIFE IN SCHIZOPHRENIA AND BIPOLAR-I-DISORDER
Publicado: (2020)

M37. THERAPEUTIC EFFECT OF TRANSCRANIAL DIRECT CURRENT STIMULATION ON WORKING MEMORY OF PATIENTS WITH RECENT ONSET SCHIZOPHRENIA: A RANDOMIZED CONTROLLED STUDY
por: Farhang, Sara, et al.
Publicado: (2020)

M64. ADDRESSING THE ROLE OF TIMING ON COGNITION IN SCHIZOPHRENIA
por: Alústiza, Irene, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ak0imidpgagra519u40lcmq5df